Titre : Virion

Virion : Questions médicales fréquentes

Termes MeSH sélectionnés :

Up-Regulation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Virion : Questions médicales les plus fréquentes", "headline": "Virion : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Virion : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-12", "dateModified": "2025-03-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Virion" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Structures virales", "url": "https://questionsmedicales.fr/mesh/D056224", "about": { "@type": "MedicalCondition", "name": "Structures virales", "code": { "@type": "MedicalCode", "code": "D056224", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A21" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Nucléocapside", "alternateName": "Nucleocapsid", "url": "https://questionsmedicales.fr/mesh/D019251", "about": { "@type": "MedicalCondition", "name": "Nucléocapside", "code": { "@type": "MedicalCode", "code": "D019251", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A21.249.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Capside", "alternateName": "Capsid", "url": "https://questionsmedicales.fr/mesh/D002213", "about": { "@type": "MedicalCondition", "name": "Capside", "code": { "@type": "MedicalCode", "code": "D002213", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A21.249.500.250" } } } ] }, { "@type": "MedicalWebPage", "name": "Enveloppe virale", "alternateName": "Viral Envelope", "url": "https://questionsmedicales.fr/mesh/D000086942", "about": { "@type": "MedicalCondition", "name": "Enveloppe virale", "code": { "@type": "MedicalCode", "code": "D000086942", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A21.249.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Virion", "alternateName": "Virion", "code": { "@type": "MedicalCode", "code": "D014771", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tibor Füzik", "url": "https://questionsmedicales.fr/author/Tibor%20F%C3%BCzik", "affiliation": { "@type": "Organization", "name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic." } }, { "@type": "Person", "name": "Pavel Plevka", "url": "https://questionsmedicales.fr/author/Pavel%20Plevka", "affiliation": { "@type": "Organization", "name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic pavel.plevka@ceitec.muni.cz." } }, { "@type": "Person", "name": "Liya Mukhamedova", "url": "https://questionsmedicales.fr/author/Liya%20Mukhamedova", "affiliation": { "@type": "Organization", "name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic." } }, { "@type": "Person", "name": "Antonín Přidal", "url": "https://questionsmedicales.fr/author/Anton%C3%ADn%20P%C5%99idal", "affiliation": { "@type": "Organization", "name": "Department of Zoology, Fishery, Hydrobiology, and Apidology, Faculty of Agronomy, Mendel University in Brno, Zemědělská 1/1665, 613 00 Brno, Czech Republic." } }, { "@type": "Person", "name": "Michael Way", "url": "https://questionsmedicales.fr/author/Michael%20Way", "affiliation": { "@type": "Organization", "name": "Cellular Signalling and Cytoskeletal Function Laboratory, The Francis Crick Institute, London, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.", "datePublished": "2022-06-27", "url": "https://questionsmedicales.fr/article/35761386", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13018-022-03181-7" } }, { "@type": "ScholarlyArticle", "name": "LncRNA FEZF1-AS1 promotes pulmonary fibrosis via up-regulating EZH2 and targeting miR-200c-3p to regulate the ZEB1 pathway.", "datePublished": "2024-10-30", "url": "https://questionsmedicales.fr/article/39472569", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-74570-7" } }, { "@type": "ScholarlyArticle", "name": "Daidzein attenuated paclitaxel-induced neuropathic pain via the down-regulation of TRPV1/P2Y and up-regulation of Nrf2/HO-1 signaling.", "datePublished": "2023-05-05", "url": "https://questionsmedicales.fr/article/37145202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10787-023-01225-w" } }, { "@type": "ScholarlyArticle", "name": "Up-Regulation of S100 Gene Family in Brain Samples of a Subgroup of Individuals with Schizophrenia: Meta-analysis.", "datePublished": "2023-04-02", "url": "https://questionsmedicales.fr/article/37005977", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12017-023-08743-4" } }, { "@type": "ScholarlyArticle", "name": "SOX21-AS1 activated by STAT6 promotes pancreatic cancer progression via up-regulation of SOX21.", "datePublished": "2022-11-05", "url": "https://questionsmedicales.fr/article/36335356", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12967-022-03521-5" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Structures virales", "item": "https://questionsmedicales.fr/mesh/D056224" }, { "@type": "ListItem", "position": 3, "name": "Virion", "item": "https://questionsmedicales.fr/mesh/D014771" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Virion - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Virion", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Virion", "description": "Comment identifier un virion dans un échantillon ?\nQuels tests sont utilisés pour détecter les virions ?\nLes virions peuvent-ils être visualisés au microscope ?\nQuelle est la méthode de culture des virions ?\nLes tests sérologiques détectent-ils les virions ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Up-Regulation&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Virion", "description": "Quels symptômes indiquent une infection virale ?\nLes virions causent-ils toujours des symptômes ?\nComment les symptômes varient-ils selon le virion ?\nLes symptômes d'une infection virale sont-ils immédiats ?\nLes virions peuvent-ils provoquer des symptômes neurologiques ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Up-Regulation&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Virion", "description": "Comment prévenir les infections virales ?\nLes masques protègent-ils contre les virions ?\nLes vaccins sont-ils efficaces contre tous les virions ?\nL'hygiène personnelle aide-t-elle à prévenir les infections ?\nLes voyages augmentent-ils le risque d'infection virale ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Up-Regulation&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Virion", "description": "Quels traitements sont efficaces contre les virions ?\nLes antibiotiques sont-ils efficaces contre les virions ?\nComment les vaccins agissent-ils contre les virions ?\nLes traitements symptomatiques sont-ils utiles ?\nLes traitements antiviraux sont-ils toujours efficaces ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Up-Regulation&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Virion", "description": "Quelles complications peuvent survenir après une infection virale ?\nLes virions peuvent-ils causer des maladies chroniques ?\nComment les complications sont-elles gérées ?\nLes complications varient-elles selon le virion ?\nLes enfants sont-ils plus à risque de complications ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Up-Regulation&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Virion", "description": "Quels sont les facteurs de risque d'infection virale ?\nLe stress affecte-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque d'infection ?\nL'environnement joue-t-il un rôle dans le risque viral ?\nLes habitudes alimentaires influencent-elles le risque viral ?", "url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Up-Regulation&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un virion dans un échantillon ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par microscopie électronique ou tests PCR." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les virions ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR, les cultures virales et les tests sérologiques sont courants." } }, { "@type": "Question", "name": "Les virions peuvent-ils être visualisés au microscope ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les virions peuvent être visualisés au microscope électronique." } }, { "@type": "Question", "name": "Quelle est la méthode de culture des virions ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les virions sont cultivés dans des cellules hôtes appropriées en laboratoire." } }, { "@type": "Question", "name": "Les tests sérologiques détectent-ils les virions ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils détectent les anticorps contre les virions, pas les virions eux-mêmes." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection virale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue, douleurs musculaires et symptômes respiratoires sont fréquents." } }, { "@type": "Question", "name": "Les virions causent-ils toujours des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains virions peuvent être asymptomatiques chez l'hôte." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon le virion ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes dépendent du type de virus et de l'hôte infecté." } }, { "@type": "Question", "name": "Les symptômes d'une infection virale sont-ils immédiats ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, il peut y avoir une période d'incubation avant l'apparition des symptômes." } }, { "@type": "Question", "name": "Les virions peuvent-ils provoquer des symptômes neurologiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains virions, comme ceux de la grippe, peuvent affecter le système nerveux." } }, { "@type": "Question", "name": "Comment prévenir les infections virales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels." } }, { "@type": "Question", "name": "Les masques protègent-ils contre les virions ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les masques réduisent la transmission des virions par voie respiratoire." } }, { "@type": "Question", "name": "Les vaccins sont-ils efficaces contre tous les virions ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Non, chaque vaccin cible des virions spécifiques et ne protège pas contre tous." } }, { "@type": "Question", "name": "L'hygiène personnelle aide-t-elle à prévenir les infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une bonne hygiène personnelle réduit le risque d'infections virales." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection virale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages peuvent exposer à de nouveaux virions et augmenter le risque d'infection." } }, { "@type": "Question", "name": "Quels traitements sont efficaces contre les virions ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux, comme l'oseltamivir, sont utilisés pour traiter certaines infections virales." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre les virions ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales." } }, { "@type": "Question", "name": "Comment les vaccins agissent-ils contre les virions ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins stimulent le système immunitaire à reconnaître et combattre les virions." } }, { "@type": "Question", "name": "Les traitements symptomatiques sont-ils utiles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils aident à soulager les symptômes, mais ne traitent pas l'infection virale." } }, { "@type": "Question", "name": "Les traitements antiviraux sont-ils toujours efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur efficacité dépend du type de virus et de la résistance virale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une infection virale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la pneumonie, la déshydratation ou des infections secondaires peuvent survenir." } }, { "@type": "Question", "name": "Les virions peuvent-ils causer des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains virions, comme le VIH, peuvent entraîner des maladies chroniques." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont gérées par des traitements symptomatiques et des soins médicaux appropriés." } }, { "@type": "Question", "name": "Les complications varient-elles selon le virion ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virion peut entraîner des complications différentes selon l'hôte." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque de complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus vulnérables aux complications des infections virales." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'infection virale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le système immunitaire affaibli et l'exposition à des porteurs." } }, { "@type": "Question", "name": "Le stress affecte-t-il le risque d'infection virale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies chroniques peuvent affaiblir l'immunité et augmenter le risque d'infection virale." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle dans le risque viral ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des environnements surpeuplés ou insalubres augmentent le risque d'infections virales." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles le risque viral ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée peut affaiblir le système immunitaire et augmenter le risque." } } ] } ] }

Sources (10000 au total)

EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.

As a skeletal malignancy, osteosarcoma has high incidence among primary malignant bone tumors. With increasing researches on molecules which mediate cancer progression, molecular mechanism has gradual... Our study aimed at investigating the function of G3BP stress granule assembly factor 2 (G3BP2), which is an oncogene for breast cancer (BC) and prostate cancer but remains unknown in osteosarcoma cell... Related gene expression was confirmed by RT-qPCR. Functional assays including immunofluorescence (IF), colony formation, transferase-mediated dUTP nick-end labeling (TUNEL) as well as transwell assays... G3BP2 was with high expression in osteosarcoma cells, and it aggravated the malignant cell behaviors in osteosarcoma. Additionally, miR-124-3p was verified to negatively regulate G3BP2 expression in o... EBF1 induced-FGA5-AS1 aggravated osteosarcoma cell malignancy by targeting miR-124-3p and G3BP2....

LncRNA FEZF1-AS1 promotes pulmonary fibrosis via up-regulating EZH2 and targeting miR-200c-3p to regulate the ZEB1 pathway.

The role and detailed mechanisms of lncRNAs in idiopathic pulmonary fibrosis (IPF) are not fully understood. qPCR was conducted to verify lncRNA FEZF1-AS1 expression in the transforming growth factor-...

SOX21-AS1 activated by STAT6 promotes pancreatic cancer progression via up-regulation of SOX21.

Pancreatic cancer (PC) is a highly malignant tumor which threatens human's health. Long non-coding RNAs (lncRNAs) are implicated in many cancers, including PC, but their mechanisms in PC have not yet ... Functional assays assessed SOX21-AS1 function on PC progression. Bioinformatics analysis, along with mechanism assays were taken to unmask the regulatory mechanism SOX21-AS1 may exert in PC cells.... SOX21-AS1 possessed a high expression level in PC cells. SOX21-AS1 absence suppressed PC cell proliferation, migration, stemness and epithelial-mesenchymal transition (EMT) while elevated cell apoptos... SOX21-AS1 aggravated the malignant development of PC, which might provide the utility value for PC treatment....

Up-regulation of matrix metalloproteinase-9 in primary bone tumors and its association with tumor aggressiveness.

Understanding the molecular mechanism underlying the pathophysiology of primary skeletal tumors is crucial due to the tumor-related complications, incidence at a young age, and tumor recurrence.... The local expression pattern of MMP-9 as an active matrix-degrading protease was detected in 180 bone tissues, including 90 tumors and 90 noncancerous tissues, utilizing real-time qRT-PCR at the mRNA ... The data propose that MMP-9 may be involved in the proliferation and invasion of primary bone tumors and has the potential to monitor and treat the progression of malignant tumors....